Stock Earnings

Question 1

Quels sont les états financiers clés de Sellas Life Sciences Group Inc ?

Accepted Answer

Selon le dernier état financier (Form-10K), Sellas Life Sciences Group Inc a un total d'actifs de $19, un bénéfice net loss de $-31

Question 2

Quels sont les ratios financiers clés pour SLS ?

Accepted Answer

Le ratio de liquidité de Sellas Life Sciences Group Inc est 2.11, la marge nette est 0, les ventes par action sont de $0.

Question 3

Comment les revenus de Sellas Life Sciences Group Inc sont-ils répartis par segment ou géographie ?

Accepted Answer

Currently Sellas Life Sciences Group Inc data is not available.

Question 4

Sellas Life Sciences Group Inc est-elle rentable ?

Accepted Answer

no, selon les derniers états financiers, Sellas Life Sciences Group Inc a un bénéfice net loss de $-31

Question 5

Sellas Life Sciences Group Inc a-t-elle des passifs ?

Accepted Answer

yes, Sellas Life Sciences Group Inc a un passif de 9

Question 6

Combien d'actions en circulation Sellas Life Sciences Group Inc a-t-elle ?

Accepted Answer

Sellas Life Sciences Group Inc a un total d'actions en circulation de 73.97

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	1	7	1
Revenue Growth (YoY)	--	--	-100%	-86%	600%	--
Cost of Revenue	--	--	0	0	0	--
Gross Profit	--	--	0	0	7	--
Selling, General & Admin	11	12	13	12	11	9
Research & Development	15	--	24	20	15	9
Operating Expenses	27	32	37	32	26	18
Other Non Operating Income (Expenses)	--	0	0	0	4	0
Pretax Income	-26	-31	-37	-41	-20	-16
Income Tax Expense	--	--	0	0	0	0
Net Income	-26	-31	-37	-41	-20	-16
Net Income Growth	-24%	-16%	-10%	105%	25%	-41%
Shares Outstanding (Diluted)	98.55	61	27.77	19.4	15.48	7.98
Shares Change (YoY)	70%	120%	43%	25%	94%	212%
EPS (Diluted)	-0.26	-0.5	-1.34	-2.13	-1.34	-2.11
EPS Growth	-56%	-63%	-37%	59%	-36%	-81%
Free Cash Flow	-31	-35	-36	-28	-26	-10
Free Cash Flow Per Share	-0.31	-0.57	-1.29	-1.44	-1.67	-1.25
Gross Margin	--	--	0%	0%	100%	--
Operating Margin	0%	0%	0%	-3,100%	-271.42%	-1,600%
Profit Margin	0%	0%	0%	-4,100%	-285.71%	-1,600%
Free Cash Flow Margin	0%	0%	0%	-2,800%	-371.42%	-1,000%
EBITDA	--	--	--	--	--	--
EBITDA Margin	--	--	--	--	--	--
D&A For EBITDA	--	--	--	--	--	--
EBIT	-27	-32	-37	-31	-19	-16
EBIT Margin	0%	0%	0%	-3,100%	-271.42%	-1,600%
Effective Tax Rate	--	--	0%	0%	0%	0%

Sellas Life Sciences Group Inc (SLS) Price